Agape ATP Corporation

As of June 30, 2026, Agape ATP Corporation carries a market capitalization of 2.96M, placing it among publicly traded companies globally. Its enterprise value stands at 2.98M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Agape ATP Corporation has 1.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 2.80, and the price-to-book ratio stands at 0.13.

These figures are as of June 30, 2026. The EV/Sales ratio of 2.82 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.98M versus a market cap of 2.96M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Agape ATP Corporation maintains a current ratio of 8.45, meaning it holds 8.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Agape ATP Corporation posted a negative return on equity (ROE) of -5.01, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -4.58, reflecting losses generated across the asset base. The company generates approximately 60,404.40 in revenue per employee across its workforce of 17.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 14.24 indicates how many times Agape ATP Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Agape ATP Corporation recorded 2,285.00 in income tax expense. The company reported a pretax loss of -1.23M and -1.14M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Agape ATP Corporation's stock has declined approximately 97.63% over the past 52 weeks. The 50-day moving average sits at 2.19, while the 200-day moving average is 2.73.

Over the twelve months ended June 30, 2026, Agape ATP Corporation generated 1.06M in revenue and converted that into -1.14M in net income, yielding earnings per share of -1.23. EBITDA reached -2.91M, while operating income came in at -3.13M.

As of June 30, 2026, Agape ATP Corporation holds 45,480.00 in cash and equivalents against 62,681.00 in total debt, resulting in a net debt position of -45,480.00. Total book value stands at 22.05M, with working capital of 21.90M providing operational flexibility.

Agape ATP Corporation produced -970,178.00 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -389.00 in capital expenditures, free cash flow totaled -970,567.00 - equivalent to -0.97 per share.

Over the twelve months ended June 30, 2026, Agape ATP Corporation posted a gross margin of 60.94, reflecting its pricing power and cost economics. The operating margin of -295.88 and net profit margin of -107.69 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -32.77: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -26.91, meaning Agape ATP Corporation raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Agape ATP Corporation's most recent stock split took place on February 10, 2026 with a 50:1 split ratio.

As of June 30, 2026, Agape ATP Corporation has an Altman Z-Score of 0.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.